Immunization with pre-erythrocytic antigen CelTOS from plasmodium falciparum elicits cross-species protection against heterologous challenge with Plasmodium berghei

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Bergmann Leitner, Elke S ^a   Mease, Ryan M ^a   de la Vega, Patricia ^a   Savranskaya, Tatyana ^a   Polhemus, Mark ^a   Ockenhouse, Christian ^a   Angov, Evelina ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROCYTE ANTIGEN; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 4; MALARIA VACCINE; MONTANIDE ISA 720; RECOMBINANT CELL TRAVERSAL PROTEIN FOR OOKINETES AND SPOROZOITES; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; DRUG DERIVATIVE; MANNITOL; MANNITYL OLEATE; MONOCLONAL ANTIBODY; OLEIC ACID; PARASITE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CODON; CONTROLLED STUDY; CROSS PROTECTION; DOSE RESPONSE; DRUG DOSE COMPARISON; ESCHERICHIA COLI; GENE EXPRESSION; HETEROLOGOUS EXPRESSION; HUMORAL IMMUNITY; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; MALARIA; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; T LYMPHOCYTE; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; CHEMISTRY; CROSS REACTION; ERYTHROCYTE; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; METHODOLOGY; MOVEMENT (PHYSIOLOGY); PARASITOLOGY; PHYSIOLOGY; SOLUBILITY; SPOROZOITE;

MUS; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; VERTEBRATA;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, PROTOZOAN; CROSS REACTIONS; ERYTHROCYTES; ESCHERICHIA COLI; FEMALE; HEPATOCYTES; HUMANS; IMMUNIZATION; INTERFERON-GAMMA; INTERLEUKIN-4; MANNITOL; MICE; MOVEMENT; OLEIC ACIDS; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; SOLUBILITY; SPOROZOITES; T-LYMPHOCYTES;

EID: 77957894212     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012294     Document Type: Article

References (24)

1. Alonso PL, Sacarlal J, Aponte JJ, Leach A, Macete E, et al. (2004) Efficacy of the RTS,S/ASO2A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet 364: 1411-1420.
2. Sacarlal J, Aide P, Aponte JJ, Renom M, Leach A, et al. (2009) Long-term safety and efficacy of the RTS,S/ASO2A malaria vaccine in Mozambican children. J Infect Dis 200: 329-336.
3. Sharma S, Pahtak S (2008) Malaria vaccine: a current perspective. J Vector Borne Dis 45: 1-20.
4. Nussenzweig RS, Vanderberg JP, Most H, Orton C (1969) Specificity of protective immunity produced by X-irradiated Plasmodium berghei sporozoites. Nature 222: 488-489.
5. Sina BJ, Do Rosario VE, Woollett G, Sakhuja K, Hollingdale M (1983) Plasmodium falciparum sporozoite immunization protections against Plasmodium berghei sporozoite infection. Experimental Parasitol 77: 122-135.
6. Doolan DL, Southwood S, Freilich DA, Sidney J, Graber NL, et al. (2003) Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. PNAS 100: 9952-9957.
7. Kaiser K, Matuschewski K, Camargo N, Ross J, Kappe SHI (2004) Differential transcriptome profiling identifies Plasmodium genes encoding pre-erythrocytic stage-specific proteins. Mol Microbiology 51: 1221-1232.
8. Kariu T, Ishino T, Yano K, Chinzei Y, Yuda M (2006) CelTOS, a novel malarial protein that mediates transmission to mosquito and vertebrate hosts. Mol Microbiol 59: 1369-1379.
9. Angov E, Hillier CJ, Kincaid RL, Lyon JA (2008) Heterologous protein expression is enhanced by harmonizing the codon usage frequencies of the target gene with those of the expression host. PLOS One 3: e2189.
10. Stewart MJ, Vanderberg JP (1988) Malaria sporozoites leave behind trails of circumsporozoite protein during gliding motility. J Protozool 35: 389-393.
11. Cochrane AH, Aikawa M, Jeng M, Nussenzweig RS (1976) Antibody-induced ultrastructural changes of malarial sporozoites. J Immunol 116: 859-867.
12. Stewart MJ, Vanderberg JP (1988) Malaria sporozoites leave behind trails of circumsporozoite protein during gliding motility. J Protozool 35: 389-393.
13. Ockenhouse EB, Bergmann-Leitner E, Riley M, D'Ambrosio J, Lee H, et al. (2009) Genetic diversity in the Plasmodium falciparum and P.vivax malaria Celtos gene from Southeast Asia, Africa and South America reveals a highly conserved gene with focal regions of non-synonymous mutations under immune selective pressure confirmed by gene sequencing, 3D structure prediction and peptide mapping. Am J Trop Med Hyg 81: 260.
14. Takala SL, Plowe CV (2009) Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming "vaccine resistant malaria". Parasite Immunol 31: 560-573.
15. Kim YT, Siskind GW (1974) Studies on the control of antibody synthesis. VI. Effect of antigen dose and time after immunization on antibody affinity and heterogeneity in the mouse. Clin Exp Immunol 17: 329-338.
16. Rees W, Bender J, Teague TK, Kedl RM, Crawford F, et al. (1999) An inverse relationship between T cell receptor affinity and antigen dose during CD4+ T cell responses in vivo and in vitro. Proc Natl Acad Sci U S A 96: 9781-9786.
17. Leitner WW, Seguin MC, Ballou WR, Seitz JP, Schultz AM, et al. (1997) Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites. J Immunol 159: 6112-6119.
18. Scheiblhofer S, Chen D, Weiss R, Khan F, Mostbock S, et al. (2001) Removal of the circumsporozoite protein (CSP) glycosylphosphatidylinositol signal sequence from a CSP DNA vaccine enhances induction of CSP-specific Th2 type immune responses and improves protection against malaria infection. Eur J Immunol 31: 692-698.
19. Weiss R, Leitner WW, Scheiblhofer S, Chen D, Bernhaupt A, et al. (2000) Genetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite protein. Infect Immun 68: 5914-5919.
20. Darko CA, Angov E, Collins WE, Bergmann-Leitner ES, Girouard AS, et al. (2005) The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites. Infect Immun 73: 287-297.
21. Bergmann-Leitner ES, Scheiblhofer S, Weiss R, Duncan EH, Leitner WW, et al. (2005) C3d binding to the circumsporozoite protein carboxy-terminus deviates immunity against malaria. Int Immunol 17: 245-255.
22. Vulliet R (1996) Improved technique for the preparation of water-in-oil emulsions containing protein antigens. BioTechniques 20: 797-800.
23. Ozaki LS, Gwadz RW, Godson GN (1984) Simple centrifugation method for rapid separation of sporozoites from mosquitoes. J Parasitol 70: 831-833.
24. Leitner WW, Bergmann-Leitner ES, Angov E (2010) Comparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacy. Mal J 9: e145.